HOME > BUSINESS
BUSINESS
- Nichi-Iko Takes Full Control of Eisai Generic Arm, Now Renamed “Elmed”
April 2, 2019
- Entyvio SC Form Now under EMA Review: Takeda
April 2, 2019
- Chugai Offloading Antiulcer Drug Ulcerlmin to Fuji Chemical
April 2, 2019
- Novel Antibiotic Cefiderocol Accepted for EMA Review: Shionogi
April 2, 2019
- Mundipharma, Maruishi to Copromote Tapenta from June
April 2, 2019
- GSK, Daiichi Sankyo Vaccine Joint Venture Dissolved
April 2, 2019
- Mochida Aims at 108 Billion Yen Sales in FY2021: New 3-Year Biz Plan
April 2, 2019
- Pfizer, Mochida Tie Up for Antidepressant Desvenlafaxine in Japan
April 2, 2019
- Takeda Files Adcetris for PTCL, Pediatric Use in Japan
April 1, 2019
- Daiichi Sankyo Bags US$6.9 Billion AstraZeneca Pact for Cancer Hopeful DS-8201, Announces CEO Change
April 1, 2019
- Safety Monitoring Board Backs PIII Continuation for Elenbecestat: Eisai
April 1, 2019
- Chugai Files for Gene Test for Companion Diagnostic to Lynparza
April 1, 2019
- Takeda Spin-Off Startup Chordia Raises 3 Billion Yen to Fund Oncology R&D
April 1, 2019
- Sumitomo Dainippon Carves Out Pain Program, 2025 Launch Eyed for Rare Pediatric Disease
March 29, 2019
- Janssen Files Stelara for Ulcerative Colitis in Japan
March 29, 2019
- Ono Seeks Japan Approval for Opdivo in MSI-H Colorectal Cancer
March 29, 2019
- Pfizer Japan to Stop Hiring Smokers
March 29, 2019
- Astellas/Seattle Genetics’ ADC Succeeds in PII Urothelial Cancer Study; US Filing Set for 2nd Half of 2019
March 29, 2019
- After 70% Pricing OK’ed for Biosame, Nesp Biosimilar Developers Stay Pat on November Listing Plans
March 28, 2019
- Ono Hooks Up with UK Charities in Cancer Immunotherapy
March 28, 2019
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
